beòcarta: biofuels, biotech, biorefineries
global services, global contacts
Since 1985 beòcarta has worked as an R&D consultancy with biomanufacturers in Europe, North America, Japan, India and the Republic of Korea to improve industrial bioprocesses at industrial scale of production:
- Clavulanic Acid (150,000 L)
- Penicillins V and G (100,000 – 200,000 L)
- Lysine (700,000 L)
- Acarbose (30,000 L)
- Chlortetracycline (250,000 L)
- Erythromycin (100,000 L)
- Vitamin B2 (100,000 L)
- Avoparcin α (vancomycin-type antibiotic) (50,000 L)
- Proteases (50,000 – 150,000 L)
- Amyloglucosidase (50,000 – 150,000 L)
- Macrolide secondary product bioactives (60,000 – 100,000 L)
- Rifamycin (90,000 L)
- Fungal depsipeptide anthelmintic (15,000 L)
- Lovastatin (10,000 L)
Collaborations have extended to the scale up of novel bioprocesses with bacterial, fungal and animal cell cultures from laboratory (< 1 L) to pilot (1000 L) scales.
